Syngene International Ltd Hits Intraday Low Amid Price Pressure

Jan 27 2026 11:02 AM IST
share
Share Via
Syngene International Ltd experienced a significant intraday decline on 27 Jan 2026, touching a new 52-week low of Rs 499.6 as the stock faced intense selling pressure. The healthcare services company underperformed its sector and broader market indices, continuing a prolonged downtrend amid a cautious market environment.
Syngene International Ltd Hits Intraday Low Amid Price Pressure



Intraday Performance and Price Movement


On the trading day, Syngene International Ltd’s share price fell sharply by 7.92%, marking its lowest level in the past year at Rs 499.6. This intraday low was accompanied by high volatility, with the stock exhibiting a 5.85% intraday price range based on the weighted average price. The steep decline outpaced the broader Sensex index, which was down 0.32% at 81,280.40 points after opening 100.91 points lower.


The stock’s performance was notably weaker than its sector peers, underperforming the healthcare services sector by 8.09% on the day. This marked the ninth consecutive day of losses for Syngene International Ltd, during which it has declined by 21.15%, reflecting sustained downward momentum.



Technical Indicators and Moving Averages


Technically, Syngene International Ltd is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This broad-based weakness across multiple timeframes indicates persistent selling pressure and a lack of short-term support levels. The stock’s current Mojo Score stands at 28.0, with a Mojo Grade of Strong Sell, an upgrade from its previous Sell rating as of 19 Jan 2026, signalling deteriorating technical and fundamental conditions.




Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!



  • - Highest rated stock selection

  • - Multi-parameter screening cleared

  • - Large Cap quality pick


View Our Top 1% Pick →




Comparative Performance Against Benchmarks


Syngene International Ltd’s recent performance starkly contrasts with the broader market. Over the past one day, the stock declined by 8.01%, while the Sensex fell by only 0.35%. Over the last week, the stock’s loss widened to 17.57%, compared to a 1.13% drop in the Sensex. The one-month and three-month returns for Syngene International Ltd stand at -23.71% and -24.41% respectively, significantly underperforming the Sensex’s corresponding declines of 4.45% and 4.16%.


Year-to-date, the stock has shed 23.32% of its value, while the Sensex has declined by 4.65%. Over a longer horizon, the stock’s one-year return is down 34.64%, contrasting with the Sensex’s positive 7.81% gain. Even over three and five years, Syngene International Ltd has underperformed the benchmark by a wide margin, with returns of -12.07% and -15.30% respectively, against Sensex gains of 36.95% and 71.39%. This extended underperformance highlights the stock’s ongoing challenges relative to the broader market.



Market Sentiment and Sector Context


The broader market environment has been subdued, with the Sensex on a three-week consecutive decline, losing 2.75% in that period. The index is currently trading below its 50-day moving average, although the 50-day average remains above the 200-day average, indicating a mixed medium-term trend. Additionally, other indices such as NIFTY MEDIA and NIFTY REALTY also hit new 52-week lows on the same day, reflecting sectoral pressures and cautious investor sentiment.


Within this context, Syngene International Ltd’s sharp intraday fall and new 52-week low underscore the heightened price pressure facing the stock. The company’s market capitalisation grade remains low at 3, consistent with its current valuation challenges.




Holding Syngene International Ltd from Healthcare Services? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!



  • - Peer comparison ready

  • - Superior options identified

  • - Cross market-cap analysis


Switch to Better Options →




Volatility and Trading Dynamics


Syngene International Ltd’s intraday volatility of 5.85% is indicative of active trading and fluctuating investor sentiment throughout the session. The stock’s inability to hold above key moving averages suggests that selling interest remains dominant. The persistent decline over nine consecutive sessions further emphasises the prevailing negative momentum.


Despite the healthcare services sector generally being viewed as defensive, Syngene International Ltd’s performance today and over recent weeks signals that it is not insulated from broader market pressures. The stock’s relative weakness compared to the sector and benchmark indices highlights the specific challenges it faces in maintaining investor confidence.



Summary of Key Metrics


To summarise, Syngene International Ltd’s key performance indicators as of 27 Jan 2026 are:



  • Intraday low: Rs 499.6 (new 52-week low)

  • Day change: -7.92%

  • Consecutive days of decline: 9

  • 9-day cumulative return: -21.15%

  • Mojo Score: 28.0 (Strong Sell)

  • Market Cap Grade: 3

  • Underperformance vs Sensex (1 day): -7.66%

  • Underperformance vs Sensex (1 month): -19.26%


These figures reflect a stock under considerable price pressure amid a cautious market backdrop and sector headwinds.



Conclusion


Syngene International Ltd’s intraday low and steep decline on 27 Jan 2026 illustrate the immediate pressures weighing on the stock. The combination of technical weakness, sustained selling over multiple sessions, and broader market softness has contributed to the stock’s underperformance. While the healthcare services sector remains under watch, Syngene International Ltd’s current trading levels and volatility underscore the challenges it faces in regaining upward momentum in the near term.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News